Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice.
AUTOR(ES)
Hunter, C A
RESUMO
The immunopathology of Trypanosoma brucei brucei in the central nervous system was studied by using an experimental model of chronic meningoencephalitis in outbred CD-1 mice. Mice infected with T. b. brucei were treated with a subcurative dose of the trypanocidal compound diaminazine aceturate. These mice relapsed and were again drug treated. The brains were examined histologically and by immunocytochemistry to identify activated astrocytes. The polymerase chain reaction was used to detect cytokine RNA transcripts. The infected and treated animals developed severe chronic meningoencephalitis characterized by large numbers of inflammatory cells and widespread astrocyte proliferation. In uninfected controls, only interleukin 1 and beta-actin RNA transcripts were detected while transcripts for beta-actin, tumor necrosis factor alpha, macrophage inflammatory protein 1 and interleukins 1 and 4 were demonstrated in the brains of infected animals. Gamma interferon and interleukin 6 were also detected in a few of the infected animals, but interleukin 2 was not found in any of these animals.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=259089Documentos Relacionados
- Pathogenesis of anemia in Trypanosoma brucei-infected mice.
- Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice.
- Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei
- Trypanosoma brucei CTP synthetase: A target for the treatment of African sleeping sickness
- Early expression of cytokine mRNA in mice infected with Listeria monocytogenes.